Alliancebernstein L.P. Avidity Biosciences, Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 127,770 shares of RNA stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127,770

Previous 127,770 -0.0%

Holding current value

$3.91 Million

Previous $3.72 Million 1.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$29.08 - $52.5 $1.25 Million - $2.25 Million	-42,914 Reduced 25.14%	127,770 $3.72 Million
Q3 2024 Nov 14, 2024	SELL	$37.21 - $48.14 $1.69 Million - $2.19 Million	-45,544 Reduced 21.06%	170,684 $7.84 Million
Q2 2024 Aug 14, 2024	SELL	$22.73 - $40.85 $2.55 Million - $4.59 Million	-112,298 Reduced 34.18%	216,228 $8.83 Million
Q1 2024 May 14, 2024	SELL	$9.16 - $25.52 $422,734 - $1.18 Million	-46,150 Reduced 12.32%	328,526 $8.38 Million
Q4 2023 Feb 14, 2024	SELL	$4.87 - $9.37 $744,812 - $1.43 Million	-152,939 Reduced 28.99%	374,676 $3.39 Million
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $2.28 Million - $4.11 Million	362,215 Added 218.99%	527,615 $3.37 Million
Q2 2023 Aug 15, 2023	BUY	$10.62 - $17.34 $1.27 Million - $2.08 Million	119,900 Added 263.52%	165,400 $1.83 Million
Q1 2023 May 15, 2023	SELL	$15.35 - $25.65 $2.5 Million - $4.17 Million	-162,560 Reduced 78.13%	45,500 $698,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $892,261 - $2.01 Million	88,694 Added 74.3%	208,060 $4.62 Million
Q3 2022 Nov 15, 2022	SELL	$15.46 - $23.43 $2.36 Million - $3.58 Million	-152,923 Reduced 56.16%	119,366 $1.95 Million
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $1.46 Million - $2.67 Million	130,280 Added 91.74%	272,289 $3.96 Million
Q1 2022 May 13, 2022	SELL	$14.2 - $23.78 $75,359 - $126,200	-5,307 Reduced 3.6%	142,009 $2.62 Million
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $3.01 Million - $4.22 Million	147,316 New	147,316 $3.5 Million
Q3 2021 Nov 10, 2021	SELL	$18.16 - $25.21 $194,312 - $269,747	-10,700 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$19.62 - $29.26 $209,934 - $313,082	10,700 New	10,700 $264,000
Q3 2020 Nov 12, 2020	SELL	$23.35 - $35.94 $233,500 - $359,400	-10,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$26.62 - $31.5 $266,200 - $315,000	10,000 New	10,000 $283,000

Others Institutions Holding RNA

# of Institutions

244

Shares Held

116M

Call Options Held

289K

Put Options Held

998K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.59B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Avidity Biosciences, Inc. Transaction History